• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.65% Nasdaq Down1.89%

    Theravance Inc. (THRX)

    -NasdaqGS
    11.48 0.30(2.55%) Jan 27, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
    Total Revenue 999   165   1,699   415  
    Cost of Revenue -  188   -   -  
    Gross Profit 999   (23) 1,699   415  
    Operating Expenses
    Research Development1,909  43,387  118,626  2,104  
    Selling General and Administrative8,632  22,834  30,558  6,018  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (9,542) (66,244) (147,485) (7,707)
    Income from Continuing Operations
    Total Other Income/Expenses Net348  185  209  156  
    Earnings Before Interest And Taxes(9,194)(66,059)(147,276)(7,551)
    Interest Expense12,355  1,644  1,686  1,901  
    Income Before Tax(21,549)(67,703)(148,962)(9,452)
    Income Tax Expense(278) -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,271)(67,703)(148,962)(9,452)
    Non-recurring Events
    Discontinued Operations -   -  99,033  (37,531)
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,271) (67,703) (49,929) (46,983)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,271) (67,703) (49,929) (46,983)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.